{
    "hands_on_practices": [
        {
            "introduction": "While the one-step 75-g Oral Glucose Tolerance Test (OGTT) is widely adopted, the two-step approach using a 100-g OGTT remains a common diagnostic strategy, especially in the United States. This method is complicated by the existence of multiple diagnostic criteria, primarily the National Diabetes Data Group (NDDG) and the stricter Carpenter-Coustan thresholds. This practice  will sharpen your ability to apply and contrast these different frameworks, a crucial skill for accurate diagnosis and for interpreting diverse clinical data and literature.",
            "id": "4445347",
            "problem": "A pregnant patient at $26$ weeks' gestation with no prior history of diabetes undergoes a diagnostic Oral Glucose Tolerance Test (OGTT) after an elevated $50$-g screening challenge. The diagnostic test is a $100$-g, $3$-hour OGTT with the following venous plasma glucose values: fasting $99$ mg/dL, $1$-hour $176$ mg/dL, $2$-hour $162$ mg/dL, and $3$-hour $138$ mg/dL. Without assuming any specific institutional policy, and using established diagnostic frameworks for the $100$-g OGTT, select the single best classification and justification regarding whether this test meets criteria for Gestational Diabetes Mellitus (GDM).\n\nA. Diagnoses GDM under Carpenter–Coustan thresholds because two values are abnormal; does not meet National Diabetes Data Group thresholds\n\nB. Diagnoses GDM under National Diabetes Data Group thresholds because two values are abnormal; does not meet Carpenter–Coustan thresholds\n\nC. Diagnoses GDM under both Carpenter–Coustan and National Diabetes Data Group thresholds\n\nD. Does not diagnose GDM under either Carpenter–Coustan or National Diabetes Data Group thresholds because only one value is abnormal\n\nE. Indeterminate and should be repeated because the $3$-hour value is below its cutoff",
            "solution": "## Problem Validation\n\n### Step 1: Extract Givens\nThe problem provides the following information:\n-   **Patient Profile:** Pregnant, at $26$ weeks' gestation.\n-   **Clinical History:** No prior history of diabetes.\n-   **Screening Test:** An elevated $50$-g glucose challenge test.\n-   **Diagnostic Test:** A $100$-g, $3$-hour Oral Glucose Tolerance Test (OGTT).\n-   **OGTT Results (Venous Plasma Glucose):**\n    -   Fasting: $99$ mg/dL\n    -   $1$-hour: $176$ mg/dL\n    -   $2$-hour: $162$ mg/dL\n    -   $3$-hour: $138$ mg/dL\n-   **Task:** Classify the test results for Gestational Diabetes Mellitus (GDM) using the National Diabetes Data Group (NDDG) and Carpenter–Coustan (C-C) diagnostic frameworks.\n\n### Step 2: Validate Using Extracted Givens\n1.  **Scientifically Grounded:** The problem is firmly rooted in standard obstetric and endocrinological practice. The screening and diagnostic protocol for GDM described (a two-step approach with a $50$-g screen followed by a $100$-g diagnostic OGTT) is a widely used and validated method, particularly in the United States. The glucose values are provided in standard units (mg/dL). The question requires the application of well-established, historical diagnostic criteria (NDDG and C-C).\n2.  **Well-Posed:** The problem is well-posed. It provides all necessary data (four glucose measurements) to apply the specified diagnostic criteria. The question is clear and asks for a specific classification based on defined rules, leading to a unique, determinable answer.\n3.  **Objective:** The problem is stated objectively, using precise clinical terminology and quantitative data. It avoids subjective or ambiguous language.\n\n### Step 3: Verdict and Action\nThe problem statement is valid. It is scientifically sound, well-posed, and objective. I will proceed with deriving the solution.\n\n## Solution Derivation\n\nThe diagnosis of Gestational Diabetes Mellitus (GDM) using a $100$-g, $3$-hour Oral Glucose Tolerance Test (OGTT) is based on comparing the patient's plasma glucose levels at four time points (fasting, $1$-hour, $2$-hour, and $3$-hour) to established thresholds. A diagnosis of GDM is made if at least two of the four values meet or exceed the specified cutoffs. The problem asks for this comparison against two different sets of criteria: the National Diabetes Data Group (NDDG) criteria and the Carpenter–Coustan (C-C) criteria.\n\nThe thresholds for each set of criteria are as follows:\n\n**1. National Diabetes Data Group (NDDG) Criteria:**\n-   Fasting: $\\geq 105$ mg/dL\n-   $1$-hour: $\\geq 190$ mg/dL\n-   $2$-hour: $\\geq 165$ mg/dL\n-   $3$-hour: $\\geq 145$ mg/dL\n\n**2. Carpenter–Coustan (C-C) Criteria:**\n-   Fasting: $\\geq 95$ mg/dL\n-   $1$-hour: $\\geq 180$ mg/dL\n-   $2$-hour: $\\geq 155$ mg/dL\n-   $3$-hour: $\\geq 140$ mg/dL\n\nThe patient's measured values are:\n-   Fasting: $99$ mg/dL\n-   $1$-hour: $176$ mg/dL\n-   $2$-hour: $162$ mg/dL\n-   $3$-hour: $138$ mg/dL\n\nNow, we will compare the patient's results to each set of criteria.\n\n**Analysis using NDDG Criteria:**\n-   Fasting: $99$ mg/dL is less than the threshold of $105$ mg/dL. (Normal)\n-   $1$-hour: $176$ mg/dL is less than the threshold of $190$ mg/dL. (Normal)\n-   $2$-hour: $162$ mg/dL is less than the threshold of $165$ mg/dL. (Normal)\n-   $3$-hour: $138$ mg/dL is less than the threshold of $145$ mg/dL. (Normal)\nUnder the NDDG criteria, there are $0$ abnormal values. Since two or more abnormal values are required for diagnosis, the patient **does not** meet the criteria for GDM.\n\n**Analysis using Carpenter–Coustan (C-C) Criteria:**\n-   Fasting: $99$ mg/dL is greater than or equal to the threshold of $95$ mg/dL. (**Abnormal**)\n-   $1$-hour: $176$ mg/dL is less than the threshold of $180$ mg/dL. (Normal)\n-   $2$-hour: $162$ mg/dL is greater than or equal to the threshold of $155$ mg/dL. (**Abnormal**)\n-   $3$-hour: $138$ mg/dL is less than the threshold of $140$ mg/dL. (Normal)\nUnder the C-C criteria, there are $2$ abnormal values (the fasting and $2$-hour results). Since two or more abnormal values are found, the patient **does** meet the criteria for a diagnosis of GDM.\n\n**Conclusion:** The test diagnoses GDM according to Carpenter-Coustan criteria but not according to NDDG criteria.\n\n## Option-by-Option Analysis\n\n**A. Diagnoses GDM under Carpenter–Coustan thresholds because two values are abnormal; does not meet National Diabetes Data Group thresholds**\nThis statement accurately reflects our derivation. The Carpenter-Coustan criteria are met with two abnormal values (Fasting: $99 \\ge 95$; $2$-hour: $162 \\ge 155$). The National Diabetes Data Group criteria are not met, as all four values are below the NDDG thresholds.\n**Verdict: Correct.**\n\n**B. Diagnoses GDM under National Diabetes Data Group thresholds because two values are abnormal; does not meet Carpenter–Coustan thresholds**\nThis statement is incorrect. The patient does not meet NDDG thresholds (zero abnormal values), but does meet Carpenter-Coustan thresholds (two abnormal values). This option reverses the correct conclusion.\n**Verdict: Incorrect.**\n\n**C. Diagnoses GDM under both Carpenter–Coustan and National Diabetes Data Group thresholds**\nThis statement is incorrect. The patient only meets the criteria for diagnosis under the Carpenter-Coustan framework, not the NDDG framework.\n**Verdict: Incorrect.**\n\n**D. Does not diagnose GDM under either Carpenter–Coustan or National Diabetes Data Group thresholds because only one value is abnormal**\nThis statement is incorrect on two counts. First, under Carpenter-Coustan criteria, there are two abnormal values, not one. Second, because there are two abnormal values, a diagnosis of GDM is made under that framework.\n**Verdict: Incorrect.**\n\n**E. Indeterminate and should be repeated because the $3$-hour value is below its cutoff**\nThis statement is incorrect. An OGTT is interpreted by the number of values that meet or exceed predefined thresholds. A value being below the cutoff is a normal finding for that time point and does not render the test indeterminate or invalid. The test is definitive based on the two elevated values under C-C criteria.\n**Verdict: Incorrect.**",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "Following a diagnosis of Gestational Diabetes Mellitus (GDM), the initial management strategy involves medical nutrition therapy and physical activity. However, when these lifestyle modifications fail to achieve glycemic control, initiating pharmacotherapy becomes necessary. This decision is based on a careful analysis of self-monitored blood glucose (SMBG) patterns against established targets. This exercise  simulates this critical clinical decision point, providing practice in interpreting real-world glucose logs to determine when to escalate care.",
            "id": "4445340",
            "problem": "A pregnant patient with Gestational Diabetes Mellitus (GDM) at $30$ weeks of gestation has completed $1$ week of medical nutrition therapy and moderate-intensity physical activity, and brings capillary glucose logs measured by a calibrated home glucometer. She checks fasting each morning and $1$-hour postprandial after each main meal.\n\nFasting values (morning, days $1$–$7$): $92$, $96$, $94$, $97$, $100$, $105$, $93$ mg/dL.\n\nOne-hour postprandial values by day (breakfast, lunch, dinner):\n- Day $1$: $142$, $148$, $135$ mg/dL\n- Day $2$: $150$, $138$, $145$ mg/dL\n- Day $3$: $155$, $144$, $139$ mg/dL\n- Day $4$: $141$, $152$, $147$ mg/dL\n- Day $5$: $135$, $149$, $153$ mg/dL\n- Day $6$: $137$, $146$, $151$ mg/dL\n- Day $7$: $143$, $136$, $150$ mg/dL\n\nBased on widely accepted glycemic targets for Gestational Diabetes Mellitus (GDM) and standard criteria used to initiate pharmacotherapy after lifestyle intervention, which of the following is the best next step, and what specific metric most directly supports the decision?\n\nA. Continue nutrition and activity counseling without pharmacotherapy; decision guided by acceptable weekly mean glucose values overall.\n\nB. Initiate pharmacotherapy; the decision is driven by the proportion of $1$-hour postprandial values exceeding the target threshold on more than $30\\%$ of measurements.\n\nC. Initiate pharmacotherapy solely because the highest observed $1$-hour postprandial value exceeded $150$ mg/dL; decision driven by the single peak value.\n\nD. Defer treatment changes and obtain Hemoglobin A1c (HbA1c) to guide whether to initiate pharmacotherapy now.\n\nE. Initiate pharmacotherapy; the decision is driven by the average fasting glucose exceeding the threshold, despite most postprandials being near target.",
            "solution": "The problem statement is evaluated as valid. It presents a realistic clinical scenario in obstetrics and gynecology concerning the management of Gestational Diabetes Mellitus (GDM). The provided data are internally consistent, scientifically plausible, and sufficient to arrive at a logical clinical decision based on established medical guidelines. The problem is well-posed and objective.\n\nThe core of this problem is the application of standard clinical guidelines for GDM management to a patient's self-monitored blood glucose data. The decision to initiate pharmacotherapy after a trial of lifestyle modification (medical nutrition therapy and physical activity) is based on whether glycemic targets are met.\n\nFirst, we must establish the widely accepted glycemic targets for GDM, as referenced in the problem statement. According to the American College of Obstetricians and Gynecologists (ACOG), these targets are:\n- Fasting glucose: $\\leq 95$ mg/dL\n- One-hour postprandial glucose: $\\leq 140$ mg/dL\n- Two-hour postprandial glucose: $\\leq 120$ mg/dL\n\nThe patient is monitoring fasting and $1$-hour postprandial values, so the relevant targets are $\\leq 95$ mg/dL and $\\leq 140$ mg/dL, respectively. Pharmacotherapy is typically indicated if a significant proportion of glucose values (often considered to be $\\geq 30\\%$ to $\\geq 50\\%$) remain above these targets after a $1$ to $2$-week trial of lifestyle changes.\n\nNext, we analyze the patient's glucose logs over the $7$-day period.\n\n1.  **Analysis of Fasting Glucose Values:**\n    - Data: $92$, $96$, $94$, $97$, $100$, $105$, $93$ mg/dL.\n    - Target: $\\leq 95$ mg/dL.\n    - Values exceeding the target: $96$, $97$, $100$, $105$ mg/dL.\n    - There are $4$ out of $7$ fasting values above the target.\n    - The proportion of elevated fasting values is $4/7 \\approx 0.571$, or $57.1\\%$.\n    - The average fasting glucose is $\\frac{92+96+94+97+100+105+93}{7} = \\frac{677}{7} \\approx 96.7$ mg/dL.\n    - Conclusion: The patient's fasting glucose levels are not adequately controlled, with both the average value and the proportion of elevated readings exceeding the target.\n\n2.  **Analysis of One-Hour Postprandial Glucose Values:**\n    - Data: There are $3$ measurements per day for $7$ days, for a total of $21$ measurements.\n    - Target: $\\leq 140$ mg/dL.\n    - Values exceeding the target are:\n        - Day $1$: $142$, $148$\n        - Day $2$: $150$, $145$\n        - Day $3$: $155$, $144$\n        - Day $4$: $141$, $152$, $147$\n        - Day $5$: $149$, $153$\n        - Day $6$: $146$, $151$\n        - Day $7$: $143$, $150$\n    - Counting these values, we find there are $15$ measurements exceeding the $140$ mg/dL target.\n    - The proportion of elevated $1$-hour postprandial values is $15/21 = 5/7 \\approx 0.714$, or $71.4\\%$.\n    - Conclusion: The patient's postprandial glucose levels are also not adequately controlled, with a very high percentage of readings above the target.\n\n**Overall Clinical Decision:**\nThe patient has failed the trial of medical nutrition therapy and physical activity, as demonstrated by a significant number of both fasting ($57.1\\%$) and postprandial ($71.4\\%$) glucose values being above the established targets. Therefore, the appropriate next step is to initiate pharmacotherapy (e.g., insulin or metformin).\n\nNow, we evaluate each option:\n\n**A. Continue nutrition and activity counseling without pharmacotherapy; decision guided by acceptable weekly mean glucose values overall.**\n- The recommendation to continue without pharmacotherapy is incorrect. The data clearly shows that glycemic targets are not being met. Both fasting and postprandial glucose levels are poorly controlled. Relying on an \"overall\" mean can be misleading and is not standard practice; decisions are based on patterns and proportions of values relative to specific fasting and postprandial thresholds.\n- **Verdict: Incorrect.**\n\n**B. Initiate pharmacotherapy; the decision is driven by the proportion of $1$-hour postprandial values exceeding the target threshold on more than $30\\%$ of measurements.**\n- The recommendation to \"initiate pharmacotherapy\" is correct.\n- The supporting metric is factually accurate based on our analysis. The proportion of high postprandial values is $71.4\\%$, which is substantially more than the clinical threshold of $30\\%$. This high rate of postprandial hyperglycemia is a sufficient and standard reason to start medication.\n- **Verdict: Correct.**\n\n**C. Initiate pharmacotherapy solely because the highest observed $1$-hour postprandial value exceeded $150$ mg/dL; decision driven by the single peak value.**\n- While the action to \"initiate pharmacotherapy\" is correct, the reasoning is clinically unsound. Management decisions for GDM are based on trends and patterns over time ($1$-$2$ weeks of data), not on a single extreme reading. Basing treatment on one value could lead to overtreatment and hypoglycemia.\n- **Verdict: Incorrect.**\n\n**D. Defer treatment changes and obtain Hemoglobin A1c (HbA1c) to guide whether to initiate pharmacotherapy now.**\n- This is an incorrect course of action. Hemoglobin A1c reflects average glycemia over the preceding $2$-$3$ months. It is not sensitive enough for the weekly or bi-weekly adjustments needed for GDM management, where rapid fetal growth necessitates tight, real-time control. The current capillary glucose data are sufficient and indicate an immediate need for intervention. Deferring treatment would be inappropriate.\n- **Verdict: Incorrect.**\n\n**E. Initiate pharmacotherapy; the decision is driven by the average fasting glucose exceeding the threshold, despite most postprandials being near target.**\n- The recommendation to \"initiate pharmacotherapy\" is correct, and the observation that the average fasting glucose exceeds the threshold ($\\approx 96.7$ mg/dL vs. a target of $\\leq 95$ mg/dL) is also correct. However, the clause \"despite most postprandials being near target\" is factually false. As calculated, $71.4\\%$ of postprandial values were *above* target. This contradictory and incorrect statement invalidates the entire rationale.\n- **Verdict: Incorrect.**\n\nBased on the analysis, Option B provides the correct clinical action supported by a factually accurate and clinically sufficient reason based on the provided data and standard guidelines. While the poor fasting control is also a strong reason, the justification provided in Option B is entirely valid and stands on its own.",
            "answer": "$$\\boxed{B}$$"
        },
        {
            "introduction": "When insulin therapy is required for GDM, calculating a safe and effective initial dose is a foundational clinical skill. This calculation is particularly critical in the third trimester, when insulin resistance peaks. This hands-on problem  guides you through a standard weight-based method for determining a patient's total daily insulin needs and partitioning it into a physiologically sound basal-bolus regimen, which mimics the body's natural insulin response.",
            "id": "4445412",
            "problem": "A pregnant patient with Gestational Diabetes Mellitus (GDM) in the third trimester has a measured body weight of $80\\,\\mathrm{kg}$. Late gestation is characterized by increased insulin resistance driven by placental hormones, necessitating higher initial insulin requirements than earlier in pregnancy. A well-tested clinical approach for an initial estimate in late gestation uses a weight-based factor of $0.9\\,\\mathrm{U\\,kg^{-1}\\,day^{-1}}$ to compute the total daily insulin dose. The physiologic rationale for a basal-bolus regimen is to partition insulin into a basal component that suppresses hepatic glucose production and a prandial component that targets postprandial glucose excursions. In late gestation, it is reasonable to allocate a greater fraction of the total daily dose to prandial insulin due to accentuated postprandial hyperglycemia from insulin resistance.\n\nStarting from these principles, derive the initial total daily insulin dose $D$ from the patient’s weight, select a physiologically justified basal fraction $\\beta$ and prandial fraction $\\gamma$ that sum to $1$ with $\\gamma>\\beta$, and distribute the prandial dose equally across three meals. Compute:\n- the total daily dose $D$ in $\\mathrm{U/day}$,\n- the basal daily dose $B$ in $\\mathrm{U/day}$,\n- the total prandial daily dose $P$ in $\\mathrm{U/day}$,\n- and the three equal per-meal prandial doses $p_1$, $p_2$, $p_3$ in $\\mathrm{U}$ per meal.\n\nRound each computed dose to two significant figures. Express all insulin quantities in international units (U). Provide your final numeric outputs in the order $D$, $B$, $P$, $p_1$, $p_2$, $p_3$ as a single row matrix without units.",
            "solution": "The problem is first validated against the established criteria.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n- Patient's body weight, $W$: $80\\,\\mathrm{kg}$\n- Patient condition: Pregnant with Gestational Diabetes Mellitus (GDM) in the third trimester.\n- Initial insulin requirement estimation factor, $f$: $0.9\\,\\mathrm{U\\,kg^{-1}\\,day^{-1}}$\n- Insulin regimen type: Basal-bolus\n- Basal fraction of total daily dose: $\\beta$\n- Prandial fraction of total daily dose: $\\gamma$\n- Constraints on fractions: $\\beta + \\gamma = 1$ and $\\gamma > \\beta$.\n- Prandial dose distribution: equally across three meals.\n- Required outputs: Total daily dose $D$, basal daily dose $B$, total prandial daily dose $P$, and per-meal prandial doses $p_1$, $p_2$, $p_3$.\n- Rounding requirement: Round each computed dose to two significant figures.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientific Grounding**: The problem is based on established clinical principles for managing GDM with insulin. The weight-based dosing factor of $0.9\\,\\mathrm{U\\,kg^{-1}\\,day^{-1}}$ is a clinically appropriate value for initial insulin estimation in late-term pregnancy. The description of a basal-bolus regimen, including the distinct roles of basal and prandial insulin, is factually correct. The stated rationale for allocating a larger fraction of the total dose to prandial insulin ($\\gamma > \\beta$) due to accentuated postprandial hyperglycemia from insulin resistance in late gestation is a standard, physiologically sound clinical strategy. The problem is scientifically grounded.\n- **Well-Posed**: The problem requires the selection of a basal fraction $\\beta$ and prandial fraction $\\gamma$ that meet specified criteria. While a specific value is not given, the problem provides sufficient clinical context (\"accentuated postprandial hyperglycemia\") and mathematical constraints ($\\beta + \\gamma = 1$, $\\gamma > \\beta$) to guide a reasoned, standard choice. A common clinical starting point that satisfies these conditions is a $40\\%/60\\%$ split ($40\\%$ basal, $60\\%$ prandial), making $\\beta=0.4$ and $\\gamma=0.6$. By selecting this standard, justifiable split, the problem becomes well-posed, with a unique solution following from the choice. All other necessary data for subsequent calculations are provided.\n- **Objective and Consistent**: The problem uses clear, precise, and objective language. It is self-contained and free of internal contradictions.\n\n**Step 3: Verdict and Action**\nThe problem is deemed **valid**. It represents a standard clinical calculation problem that requires applying given principles and making a justified choice based on the provided context. The solution process may proceed.\n\n### Solution\n\nThe solution is derived by systematically applying the principles and data provided in the problem statement.\n\n1.  **Computation of the Total Daily Insulin Dose ($D$)**\n    The total daily insulin dose, $D$, is determined by multiplying the patient's body weight, $W$, by the specified weight-based dosing factor, $f$.\n    Given:\n    - Weight $W = 80\\,\\mathrm{kg}$\n    - Dosing factor $f = 0.9\\,\\mathrm{U\\,kg^{-1}\\,day^{-1}}$\n\n    The total daily dose is:\n    $$D = W \\times f = 80\\,\\mathrm{kg} \\times 0.9\\,\\mathrm{U\\,kg^{-1}\\,day^{-1}} = 72\\,\\mathrm{U\\,day^{-1}}$$\n    To two significant figures, $D$ is $72\\,\\mathrm{U}$.\n\n2.  **Selection of Basal and Prandial Fractions ($\\beta$, $\\gamma$)**\n    The problem requires partitioning the total daily dose into a basal component and a prandial component, with fractions $\\beta$ and $\\gamma$ respectively. The constraints are $\\beta + \\gamma = 1$ and $\\gamma > \\beta$. The clinical context notes \"accentuated postprandial hyperglycemia,\" justifying a larger prandial fraction. A standard, physiologically justified starting point that satisfies these conditions is to allocate $40\\%$ of the total dose as basal insulin and $60\\%$ as prandial insulin.\n    Therefore, we select:\n    - Basal fraction: $\\beta = 0.4$\n    - Prandial fraction: $\\gamma = 0.6$\n    These values satisfy the given constraints: $0.4 + 0.6 = 1$ and $0.6 > 0.4$.\n\n3.  **Computation of the Basal Daily Dose ($B$)**\n    The basal dose, $B$, is the fraction $\\beta$ of the total daily dose $D$.\n    $$B = \\beta \\times D = 0.4 \\times 72\\,\\mathrm{U} = 28.8\\,\\mathrm{U}$$\n    Rounding this result to two significant figures yields:\n    $$B \\approx 29\\,\\mathrm{U}$$\n\n4.  **Computation of the Total Prandial Daily Dose ($P$)**\n    The total prandial dose, $P$, is the fraction $\\gamma$ of the total daily dose $D$.\n    $$P = \\gamma \\times D = 0.6 \\times 72\\,\\mathrm{U} = 43.2\\,\\mathrm{U}$$\n    Rounding this result to two significant figures yields:\n    $$P \\approx 43\\,\\mathrm{U}$$\n    A consistency check using the rounded values shows $B + P = 29\\,\\mathrm{U} + 43\\,\\mathrm{U} = 72\\,\\mathrm{U}$, which matches the rounded total daily dose $D$.\n\n5.  **Computation of the Per-Meal Prandial Doses ($p_1, p_2, p_3$)**\n    The total prandial dose $P$ is distributed equally among three meals.\n    $$p_1 = p_2 = p_3 = \\frac{P}{3}$$\n    Using the unrounded value of $P$ for calculation:\n    $$p_1 = p_2 = p_3 = \\frac{43.2\\,\\mathrm{U}}{3} = 14.4\\,\\mathrm{U}$$\n    Rounding this result to two significant figures yields:\n    $$p_1 = p_2 = p_3 \\approx 14\\,\\mathrm{U}$$\n\n6.  **Final Values**\n    The computed and rounded values for the required outputs are:\n    - Total daily dose $D = 72\\,\\mathrm{U}$\n    - Basal daily dose $B = 29\\,\\mathrm{U}$\n    - Total prandial daily dose $P = 43\\,\\mathrm{U}$\n    - Per-meal prandial dose $p_1 = p_2 = p_3 = 14\\,\\mathrm{U}$\n\nThese values will be presented in the specified matrix format.",
            "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n72 & 29 & 43 & 14 & 14 & 14\n\\end{pmatrix}\n}\n$$"
        }
    ]
}